PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
China Pharma Holdings, Inc. Comments on Unusual Market Activity
HAIKOU, China , July 22, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals ...
2026-07-22T    Banking/Financial Service   Health Care/Hospital   Medical/Pharmaceuticals 
Angel Yeast's Initiative Advances Internationally Recognized Codex Standard for baker's yeast
YICHANG, China , July 21, 2026 /PRNewswire/ -- The 49th session of the Codex Alimentarius Commission (CAC49), held in Geneva, Switzerland, from July 6 to 10, 2026, adopted a number of international ...
2026-07-21T    Biotechnology   Food/Beverages   Health Care/Hospital 
The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading?
T-MAXIMUM PHARMACEUTICAL Inc's Universal CAR-T First-in-Human Data to Debut at the World Conference on Lung Cancer ...
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
SHANGHAI , July 21, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced ...
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations
The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past two decades [1] Takeda's dengue vaccine (TAK-003) is the most extensively ...
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner
Driving Digital Transformation in Blood Management for Plasma Collection Centers, Hospitals, and Blood Bank Centers ...
2026-07-21T    Biotechnology   Computer Software   Computer/Electronics   Health Care/Hospital 
MALAYSIA HEALTHCARE BROUGHT MALAYSIA'S LEADING HOSPITALS TO HONG KONG'S MOST INFLUENTIAL HEALTHCARE AUDIENCE
HONG KONG , July 21, 2026 /PRNewswire/ -- As healthcare travellers place increasing importance on trust, quality, and patient experience, Malaysia Healthcare Travel Council (MHTC), under the Malaysia ...
2026-07-21T    Health Care/Hospital   Medical/Pharmaceuticals   Travel   Trade show news 
Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026
HONG KONG and SHANGHAI , July 21, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) unveiled ...
2026-07-21T    Banking/Financial Service   Computer Software   Computer/Electronics   Health Care/Hospital 
Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization
Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline ...
2026-07-21T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ESMO 2026 | Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation
SHANGHAI , July 21, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present the latest clinical study results ...
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.